Outlook Therapeutics CEO discusses LYTENAVA commercial launch
Kaltura officer Eynav Azaria sells $33,273 in KLTR shares
Telos EVP, CFO Gary Bendza sells $910,000 Telos common stock
Earnings call transcript: Yuanbao Insurance posts strong Q2 2026 growth, shares rise
Earnings call transcript: Macy’s beats Q2 2026 forecasts but shares fall premarket
Earnings call transcript: MasterCraft beats on Q4 2026 sales, shares rise premarket
Day 253: Lamentations of Jeremiah (2026)
Earnings call transcript: Designer Brands tops Q2 2026 profit view, lifts outlook
Wall St set for lower open after hotter-than-expected producer inflation data
Iridium and Deutsche Telekom demo satellite voice messaging